In TN BC, IGF-1 signaling is crucial for promoting cell proliferation and survival, largely by activating key pathways such as PI3K/AKT and MAPK, which support tumor growth and enable cells to resist apoptosis, underscoring its potential as a therapeutic target [52]. This evidence concerns the gene AKT1 and breast cancer.